PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer

Seema Parte, Irma Virant-Klun, Manish Patankar, Surinder K. Batra, Alex Straughn, Sham S. Kakar

Research output: Contribution to journalArticle

Abstract

Origin of cancer stem cells (CSCs) and mechanisms by which oncogene PTTG1 contributes to tumor progression via CSCs is not known. Ovarian CSCs exhibit characteristics of self-renewal, tumor-initiation, growth, differentiation, drug resistance, and tumor relapse. A common location of putative origin, namely the ovarian surface epithelium, is shared between the normal stem and CSC compartments. Existence of ovarian stem cells and their co-expression with CSC signatures suggests a strong correlation between origin of epithelial cancer and CSCs. We hereby explored a putative oncogene PTTG1 (Securin), reported to be overexpressed in various tumors, including ovarian. We report a previously overlooked role of PTTG1 as a marker of CSCs thereby modulating CSC, germline, and stemness-related genes. We further characterized PTTG1’s ability to regulate (cancer) stem cell-associated self-renewal and epithelial-mesenchymal transition pathways. Collectively, the data sheds light on a potential target expressed during ovarian tumorigenesis and metastatically disseminated ascites CSCs in the peritoneal cavity. Present study highlights this unconventional, under-explored role of PTTG1 in regulation of stem and CSC compartments in ovary, ovarian cancer and ascites and highlights it as a potential candidate for developing CSC specific targeted therapeutics.

Original languageEnglish (US)
Pages (from-to)866-879
Number of pages14
JournalStem Cell Reviews and Reports
Volume15
Issue number6
DOIs
StatePublished - Dec 1 2019

    Fingerprint

Keywords

  • Cancer stem cells
  • Oncogene
  • Ovarian cancer
  • Ovary
  • PTTG1
  • Securin
  • Stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research

Cite this